[Naltrexone in the treatment of dissociative disorders--reflections with regard to a comprehensive therapeutic concept of borderline disorders].
OBJECTIVE
Not until one year ago has it become more and more known in German speaking countries, that the treatment of borderline and posttraumatic disorders benefits from the use of opiate receptor antagonists. Prerequisite is, that psychotherapeutic approaches, pharmacotherapy and brain physiological research are integrated in an overall concept.


METHODS
We report on the current standing of scientific research and moreover our own clinical experiences with opiate antagonists are explained.


CONCLUSIONS
Our achieved knowledge permits our to present criteria how to combine these drugs and psychotherapy successfully.
Bolm
T
T
Abteilung für Psychiatrie und Psychotherapie des AK Bergedorf, Hamburg.
Piegler
T
T
D000328:Adult; D001883:Borderline Personality Disorder / Q000150:complications / Q000188:drug therapy* / Q000523:psychology; D003131:Combined Modality Therapy; D003863:Depression / Q000188:drug therapy; D004213:Dissociative Disorders / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D006801:Humans; D009271:Naltrexone / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D013811:Psychotherapeutic Processes; D011613:Psychotherapy; D016728:Self-Injurious Behavior / Q000188:drug therapy; D013313:Stress Disorders, Post-Traumatic / Q000188:drug therapy / Q000523:psychology; D016896:Treatment Outcome
D009292:Narcotic Antagonists; D009271:Naltrexone